Most HPV-positive head and neck cancer patients do well on de-intensified treatment but two Cleveland Clinic oncologists have evidence that a significant subset of this group does not.
Cleveland Clinic Head & Neck Institute surgeons apply a personalize approach to management of Zenker diverticulum, resulting in better patient outcomes.
Distant metastases may occur later and in unexpected sites in patients with HPV-positive oral cancer, indicating that new surveillance strategies may be needed. These findings reflect Cleveland Clinic’s experience over 18 years.
Cleveland Clinic head and neck surgeon Brian Burkey, MD, discusses the key roles of teamwork and education in improving functional outcomes for patients with primary and recurrent head and neck cancers.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
By Eric Lamarre, MD; Joseph Scharpf, MD; and Brian B. Burkey, MD Recent activity in the Section of Head and Neck Surgery and Oncology in Cleveland Clinic’s Head & Neck Institute has centered on two particular areas of laryngeal cancer treatment: salvage laryngectomy for recurrent laryngeal cancer and the development of a Cleveland Clinic Care … Read More
The rise of oropharyngeal cancer worldwide is attributable to a corresponding rise in human papillomavirus-related squamous cell carcinoma. Treatments must be altered accordingly.